![]() |
|
|
Vol. 292, Issue 1, 188-195, January 2000
Department of Medical Education and Research, Veterans General
Hospital-Kaohsiung (S.-N.W., H.-F.L.); and Department of Pharmacology,
Kaohsiung Medical University, Kaohsiung, Taiwan, Republic of China
(Y.-C.L.)
The effects of tetrandrine, a blocker of voltage-dependent
Ca2+ channels, on ionic currents were investigated in an
endothelial cell line (HUV-EC-C) originally derived from human
umbilical vein. In whole-cell configuration, tetrandrine (0.5-50 µM)
reversibly decreased the amplitude of K+ outward currents.
The IC50 value of tetrandrine-induced decrease in outward
current was 5 µM. The K+ outward current in response to
depolarizing voltage pulses was also inhibited by iberiotoxin (200 nM),
yet not by glibenclamide (10 µM) or apamin (200 nM). The reduced
amplitude of outward current by tetrandrine can be reversed by the
further addition of Evans' blue (30 µM) or niflumic acid (30 µM).
Thus, the tetrandrine-sensitive component of outward current is
believed to be Ca2+-activated K+ current.
Pretreatment with thapsigargin (1 µM) or sodium nitroprusside (10 µM) for 5 h did not prevent tetrandrine-mediated inhibition of
outward current. In outside-out configuration, bath application of
tetrandrine (5 µM) did not change the single-channel conductance but
significantly reduced the opening probability of large-conductance Ca2+-activated K+ (BKCa) channels.
The tetrandrine-mediated decrease in the channel activity was
independent on internal Ca2+ concentration. Tetrandrine (5 µM) can also shift the activation curve of BKCa channels
to more positive potentials by approximately 20 mV. The change in the
kinetic behavior of BKCa channels caused by tetrandrine is
due to a decrease in mean open time and an increase in mean closed
time. The present study provides substantial evidence that tetrandrine
is capable of suppressing the activity of BKCa channels in
endothelial cells. The direct inhibition of these channels by
tetrandrine should contribute to its effect on the functional
activities of endothelial cells.
This article has been cited by other articles:
![]() |
H. Zeng, E. Gordon, Z. Lin, I. M. Lozinskaya, R. N. Willette, and X. Xu 1-[1-Hexyl-6-(methyloxy)-1H-indazol-3-yl]-2-methyl-1-propanone, a Potent and Highly Selective Small Molecule Blocker of the Large-Conductance Voltage-Gated and Calcium-Dependent K+ Channel J. Pharmacol. Exp. Ther., October 1, 2008; 327(1): 168 - 177. [Abstract] [Full Text] [PDF] |
||||
![]() |
S.-N. Wu, S.-I. Liu, and M.-H. Huang Cilostazol, an Inhibitor of Type 3 Phosphodiesterase, Stimulates Large-Conductance, Calcium-Activated Potassium Channels in Pituitary GH3 Cells and Pheochromocytoma PC12 Cells Endocrinology, March 1, 2004; 145(3): 1175 - 1184. [Abstract] [Full Text] [PDF] |
||||